Clinical Trial Update: Anticancer Activity of Nicotinamide on Lung Cancer [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update reports anticancer activity of nicotinamide in non-small cell lung carcinoma across Phase 2 and Phase 3 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Nicotinamide (nicotinamide)

Snippet

Sponsor: Il Yeong Park, Ph.D. | Conditions: Non-Small-Cell Lung Carcinoma | Phase 2, Phase 3 | Status: UNKNOWN